Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

416 Views

Poster Session: PK/PD Studies

623 - Preliminary Dosing for Adolescent Hematopoietic Stem-Cell Transplant (HSCT) Recipients Based on Pharmacokinetic (PK), Safety, and Efficacy Data of Letermovir (LET) for Cytomegalovirus (CMV) Prophylaxis

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Andreas H. Groll, MD

Professor of Paediatrics, Head of the Infectious Disease Research Programme and Deputy Director of the Department of Haematology/Oncology
University Children’s Hospital
Munster, Nordrhein-Westfalen, Germany

Co-Author(s)

JS

Johannes H. Schulte, MD

Charite Universitatsmedizin
Berlin, Berlin, Germany
AA

Ali Bulent Antmen, MD, PhD

Acibadem Adana Hospital
Adana, Adana, Turkey
CF

Christopher J. Fraser, MD

Queensland Children’s Hospital
Brisbane, Queensland, Australia
VT

Valerie L. Teal, MS

Merck & Co., Inc.
Rahway, New Jersey, United States
BH

Barbara A. Haber, MD

Merck & Co., Inc.
Rahway, New Jersey, United States
LC

Luzelena Caro, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
JM

Jacqueline B. McCrea, PharmD

Merck & Co., Inc.
Rahway, New Jersey, United States
CF

Craig Fancourt, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
KM

Karsten Menzel, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
CB

Cyrus Badshah, MD, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States